Gawel
John Gawel, Nashville, TN US
Patent application number | Description | Published |
---|---|---|
20110310297 | CONSUMER ELECTRONIC PRODUCT HAVING INTEGRATED ROUTER OR GATEWAY - An example consumer electronic product such as a television includes a router or gateway contained within a housing of the television and a user interface for allowing configuration of settings associated with the router or gateway via one or more displays on a screen of the television. | 12-22-2011 |
Marek Gawel, Gumpoldskirchen AT
Patent application number | Description | Published |
---|---|---|
20150317871 | GAME DEVICE - Gaming device with a firing mechanism for shooting a game coin into a coin track, comprising a preferably arc-shaped deflection track and leading to a target device, wherein the deflection track is bordered by a recess in a housing front panel and the target device is arranged in the area of said recess, characterised in that the housing front panel is at least sectionally transparent in design, wherein behind the housing front panel, a visualisation device is arranged such that at least a portion of the visualisation device is visible through the housing front panel and/or through the recess. | 11-05-2015 |
Susan Gawel, Lagrange Park, IL US
Patent application number | Description | Published |
---|---|---|
20150057346 | METHODS OF MAINTAINING INTRAMUSCULAR MYOGLOBIN LEVELS, MAINTAINING MAXIMAL AEROBIC CAPACITY, AND ENHANCING THE OXIDATIVE CAPACITY OF MUSCLE IN A SUBJECT - Methods of maintaining intramuscular myoglobin levels, maintaining maximal aerobic capacity, and enhancing the oxidative capacity of muscle in a subject in need thereof are provided. Generally, the methods include administering an effective amount of β-hydroxy-β-methylbutyrate to the subject. The β-hydroxy-β-methylbutyrate may be administered as part of a nutritional composition. | 02-26-2015 |
20150057350 | FIBROSIS BIOMARKERS AND METHODS OF USING SAME - Methods and systems for using fibrosis biomarkers associated with a prolonged period of physical inactivity are provided. Also provided is a method of reducing the effect of prolonged physical inactivity on the development of fibrosis in a subject who is experiencing or is expected to experience prolonged physical inactivity in the near future by administering a therapeutically effective amount of a leucine metabolite (e.g., β-hydroxy-β-methylbutyric acid (HMB)) to the subject. | 02-26-2015 |